Letters
Nationalisation of drug industry
Cooperation as an alternative to nationalisation of the pharmaceutical industry
BMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m1314 (Published 02 April 2020) Cite this as: BMJ 2020;369:m1314
- Jonathan R Denfhy, fifth year medical student
- Lancaster Medical School, Lancaster University, Lancaster LA1 4YW, UK
- j.denfhy{at}gmail.com
Head to Head, 7 March
Serial title in print: Drug industry debate
Mazzucato and Li, and Darzi provide compelling arguments for and against the nationalisation of the pharmaceutical industry.1 Mazzucato and Li’s argument regarding the “short termism and misalignment of public interest” are justified criticisms of big pharma, and Darzi’s counter on the singular financial power that these companies wield is an effective response. This argument is not, however, the …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.